Adrenal cortical dysfunction as a basis for experimental hypertensive disease.
D000311:Adrenal Glands / Q000187:drug effects / Q000503:physiopathology*; D000308:Adrenocortical Hyperfunction / Q000139:chemically induced / Q000150:complications*; D045930:Anabolic Agents; D000728:Androgens; D000818:Animals; D001794:Blood Pressure; D005260:Female; D006973:Hypertension / Q000139:chemically induced / Q000209:etiology*; D008722:Methods; D008797:Metyrapone; D009929:Organ Size; D012038:Regeneration; D013739:Testosterone
D045930:Anabolic Agents; D000728:Androgens; D013739:Testosterone; D008797:Metyrapone